ZA911950B - Plasmodium sporozoite antigen - Google Patents
Plasmodium sporozoite antigenInfo
- Publication number
- ZA911950B ZA911950B ZA911950A ZA911950A ZA911950B ZA 911950 B ZA911950 B ZA 911950B ZA 911950 A ZA911950 A ZA 911950A ZA 911950 A ZA911950 A ZA 911950A ZA 911950 B ZA911950 B ZA 911950B
- Authority
- ZA
- South Africa
- Prior art keywords
- sporozoite antigen
- plasmodium sporozoite
- plasmodium
- antigen
- sporozoite
- Prior art date
Links
- 241000224016 Plasmodium Species 0.000 title 1
- 101710152205 Sporozoite antigen Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
- C07K16/205—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH97090 | 1990-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA911950B true ZA911950B (en) | 1991-11-27 |
Family
ID=4199439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA911950A ZA911950B (en) | 1990-03-23 | 1991-03-15 | Plasmodium sporozoite antigen |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0447956A1 (en) |
JP (1) | JPH0686679A (en) |
AU (1) | AU637468B2 (en) |
CA (1) | CA2037151A1 (en) |
IE (1) | IE910966A1 (en) |
IL (1) | IL97578A0 (en) |
NZ (1) | NZ237447A (en) |
PT (1) | PT97117A (en) |
ZA (1) | ZA911950B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3355095A (en) * | 1994-09-02 | 1996-03-27 | Meiji Milk Products Company Limited | Diagnostic drug for chlamydia infection |
EP1221968B1 (en) * | 1999-10-13 | 2010-01-13 | Novartis Vaccines and Diagnostics, Inc. | Method of obtaining cellular immune responses from proteins |
CA2713879C (en) * | 2008-02-01 | 2020-01-07 | Alpha-O Peptides Ag | Self-assembling peptide nanoparticles useful as vaccines |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE78869T1 (en) * | 1985-02-07 | 1992-08-15 | Smithkline Beecham Corp | MALARIA VACCINE. |
GB8615068D0 (en) * | 1986-06-20 | 1986-07-23 | Wellcome Found | Vaccines |
HUT51332A (en) * | 1987-01-30 | 1990-04-28 | Smithkline Biolog | Process for expressing p.falciparum cirkumsporozoita protein by yeast |
AU625713B2 (en) * | 1988-02-19 | 1992-07-16 | Microgenesys, Inc. | Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum |
FR2645877B1 (en) * | 1989-04-12 | 1991-07-05 | Pasteur Institut | MOLECULES COMPRISING AT LEAST ONE PEPTIDE SEQUENCE CARRYING ONE, OR SEVERAL, CHARACTERISTIC EPITOPE OF A PROTEIN PRODUCED BY P. FALCIPARUM AT THE SPOROZOITE STAGE AND IN THE HEPATOCYTES |
AU7163091A (en) * | 1989-12-12 | 1991-07-18 | Biomedical Research Institute | Novel malarial sporozoite peptide antigens |
-
1991
- 1991-02-26 CA CA002037151A patent/CA2037151A1/en not_active Abandoned
- 1991-03-14 EP EP91103900A patent/EP0447956A1/en not_active Withdrawn
- 1991-03-15 ZA ZA911950A patent/ZA911950B/en unknown
- 1991-03-15 NZ NZ237447A patent/NZ237447A/en unknown
- 1991-03-18 AU AU73589/91A patent/AU637468B2/en not_active Expired - Fee Related
- 1991-03-18 IL IL97578A patent/IL97578A0/en unknown
- 1991-03-22 JP JP3059119A patent/JPH0686679A/en active Pending
- 1991-03-22 PT PT97117A patent/PT97117A/en not_active Application Discontinuation
- 1991-03-22 IE IE096691A patent/IE910966A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2037151A1 (en) | 1991-09-24 |
NZ237447A (en) | 1993-05-26 |
AU637468B2 (en) | 1993-05-27 |
PT97117A (en) | 1991-11-29 |
IL97578A0 (en) | 1992-06-21 |
JPH0686679A (en) | 1994-03-29 |
AU7358991A (en) | 1991-10-03 |
EP0447956A1 (en) | 1991-09-25 |
IE910966A1 (en) | 1991-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG48314A1 (en) | Improved antibodies to plasmodium falciparum | |
ZA91534B (en) | Vaccines | |
ZA909838B (en) | Malaria vaccine | |
ZA911950B (en) | Plasmodium sporozoite antigen | |
GB8919064D0 (en) | Plasmodium merozoite rhoptries antigen | |
GB2251735B (en) | Rectifier | |
GB9020438D0 (en) | Plasmodium liver stage antigens | |
GB9014652D0 (en) | Antigen | |
EP0550595A4 (en) | Methods | |
GB9003678D0 (en) | Badges | |
ZA903327B (en) | Malaria vaccine | |
GB9102294D0 (en) | Antigen of plasmodium falciparum | |
GB2248024B (en) | Base structure | |
EP0439678A3 (en) | Inductor | |
GB9027381D0 (en) | Decorative members | |
EP0516721A4 (en) | Antigenic proteins of plasmodium | |
GB9020464D0 (en) | Plasmodium liver stage antigens | |
GB9020437D0 (en) | Plasmodium liver stage antigens | |
IE901300L (en) | Plasmodium circumsporozoite protein analogues | |
RU1806857C (en) | Cyclone | |
GB9017991D0 (en) | Stairs | |
AU110705S (en) | Brooch | |
AU110706S (en) | Brooch | |
GB9202491D0 (en) | Parasite antigens | |
GB9117602D0 (en) | Novel antigens |